Conversations about Life Science, Science, Business, M&A, Technology, Pharma, and Philosophy. Do you want to stay updated? Join the LSG2G Community: https://lsg2g.substack.com/
Here is the conversation with Tero Weckroth, Business Angel and Investment Expert from Finland about Public and Private Investments.
Article to the Episode: https://lsg2g.substack.com/p/44-private-and-public-investments
Video to the Episode: https://youtu.be/7WDHWOyaPQQ
Tero Weckroth: https://www.linkedin.com/in/tero-weckroth-5b927/
Podcast Website: https://ww...
Thomas Moser and Tilmann Buerckstuemmer lead the Austrian Life Science Company Aelian Biotechnology.
Article to the Episode: https://lsg2g.substack.com/p/gene-editing-the-next-game-changing-d3f
Video to the Episode: https://youtu.be/3bf7ChYUHLE
Aelian Biotechnology: https://aelian.bio/
Thomas Moser: https://www.linkedin.com/in/thomas-moser-79819a5/
Tilmann Buerckstuemmer: https://www.linkedin.com/in/tilmann-burckstummer-1...
Have you ever wondered what role the small country Austria - located in the center of Europe - plays in Life Science?
LISAvienna is a joint life science platform operated by Austria Wirtschaftsservice and the Vienna Business Agency. On behalf of the Austrian Federal Ministry for Digital and Economic Affairs and the City of Vienna, it contributes ...
This episode will discuss what it takes to build companies that develop novel therapies, vaccines, and diagnostics in the pharma industry.
Since the pandemic, everybody got familiar with the key elements of pharma product development.
But let’s take a closer look into the value chain of the industry.
What does it really take to pick up a technology and bring it to patients?
Questions we will discuss:
Some questions we will focus on:
In history, most of the time, humans needed to provide everything they needed to make a living for themselves. Trading goods were part of life but didn’t take up most of the world’s population’s time.
Industrialization changed the job profiles, the needs of workers, and the availability of goods.
In this century, many people in the western world have jobs to provide services and get what they need for getting through the day in shops...
This podcast episode will discuss the EU’s next framework program for research and innovation, Horizon Europe, and the exciting opportunities this program offers businesses, scientists, and investors. With the launch of the Horizon Europe program just weeks away, we will share insight into the program's novelties, where to start, and tips on how to be successful.
The Podcast Host, guests Kimberly Cornfield and Michael Browne wi...
In this podcast episode, we will discuss several different forms of growth and scaling up companies. In the era of the fast-growing unicorns and skyrocketing valuations, we try to disassemble the growth path and see what a founder can do to benefit most of these options.?
In this podcast episode, we will discuss how blockchain technology is utilized in the energy sector beyond the well-known utility of a payments system, her experiences in entrepreneurship and innovation, including start-up life in Berlin.
Ana Trbovich is the Grid Singularity co-founder & COO and Vice-Chair of the Energy Web Foundation. She serves on UNECE Carbon Neutrality and DENA SET Hub Advisory Boards, and previously acted a...
It was great fun to talk with Walter Stockinger, Co-Founder of Hadean Ventures, about the topic of Life Science Investments.
We covered the following questions:
Use the opportunity to get your answer directly from a VC.
This one is an episode for the go-getters and never-giveupers.
Astrid and Christian had great fun talking with Essa Saulat, Chief Growth Officer of the Austrian digital health company Symptoma.
Essa is a seasoned entrepreneur and helped many start-ups getting off the ground.
In this episode, he shares his life story of overcoming adversity, keeping moving forward relentlessly, and ultimately changing his world and the worlds of many p...
Drug Development is a challenging process. It needs profound basic research, translating scientific results into products and moving them towards the market.
Making things more challenging deal structuring is also a b2b business, which means selling products to the pharma industry that completes the product development and brings therapeutics to patients.
How does structuring deals with the pharma industry really work to sign one of ...
For more than 10 years the blockchain technology has shaped our economy. The background technology is mostly invisible for average users like me.
On the front end, cryptocurrency has hit the news. I remember well the highs of Bitcoin in 2017. And recently, Bitcoin is rising again.
But, and this is something I want to learn, what applications do exist that can improve the life science industries? Is there something else in the backgro...
A new year brings new tax rules.
Astrid Woollard and Christian Soschner asked the Tax Experts of KPMG Austria to give an update on the newest regulations in Austria.
We also had a chance to talk about tax advisors and auditors' roles in the start-up economy.
Listen to this episode to learn what's new and when to consult advisors.
If you have questions after listening to the episode, reach out to Michael and Oliver.
For the video...
What was hot and what not - in Blockchain and Life Science and other Tech Areas the speakers love.
Listen about what was going on in the world in 2020 - besides SARS CoV 2.
Albert Missbichler (https://www.linkedin.com/in/albert-missbichler-3a362931/)
Astrid Woollard (https://www.linkedin.com/in/astridwoollard/)
Christian Soschner (https://www.linkedin.com/in/christiansoschner/)
Elisabeth Pfneisl (https://www.linkedin.com/in/elis...
At the beginning of the new millennium, the next technological quantum leap began to emerge, known as the fourth industrial revolution – or Industry 4.0 for short. New technologies permit the development of new business models. In general, a business model describes a company’s business processes to achieve a defined business objective within the context of its social environment. The term sums up visions, ideas, defining features,...
One problem in the digital world is: We cannot feel the interaction.
Prof. Sriram Subramanian is working on solutions for this problem. He has spun out Ultraleap from the University of Bristol. The company translates the research into products for the digital world.
In this episode, I will talk with Prof. Subramanian about real-life applications for his inventions, the importance of touch for well-being, and the potential for the li...
Let's sit down for a conversation about my favorite topic: Fundraising in the Life Science Industry.
How is it to raise significant financing rounds during a pandemic when the research focus is not related to SARS-CoV-2?
It is my pleasure to welcome Dr. Daniela Marino, CEO and Co-founder of Cutiss AG.
Christian Soschner (https://www.linkedin.com/in/christiansoschner/)
Daniela Marino (https://www.linkedin.com/in/daniela-mar...
In the last episodes, I have talked with investors and decision-makers of the pharmaceutical industry about the importance of having a vision and passion for the life science company.
I want to explore this topic further and ask the life science entrepreneur Christof Goetz to chat with me about finding your vision and passion for your company.
Christof is a Serial Entrepreneur with more than 20 years of experience managing complex bu...
In this episode, I had the pleasure of talking with two Diagnostics Experts.
Irina Korschinek, CEO of Ingenetix and Albert Missbichler, Business Angel specialized in Diagnostics.
Do you want to know answers to all or one of the following questions?
• What is a PCR test?
• Why is it the gold standard for measuring SARS-Cov2 Infections?
• What does a positive or negative test result say?
• Why do false positives and false negatives exist. ...
Did you know that the successful pipeline of one of the most important pharmaceutical companies in the United States started in Europe, and scientists from Prague played a key role? Did you know that profound expertise in turning deep tech life science into a business, scale it, and go public in the US can be found in Prague since the late 80s of the previous century?
If you want to know which US pharmaceutical companies pipeline st...
If you can never get enough true crime... Congratulations, you’ve found your people.
We’re at our most vulnerable when we go to our doctors. We trust the person at the other end of that scalpel. We trust the hospital. We trust the system. Christopher Duntsch was a neurosurgeon who radiated confidence. He claimed he was the best in Dallas. If you had back pain, and had tried everything else, Dr. Duntsch could give you the spine surgery that would take your pain away. But soon his patients started to experience complications, and the system failed to protect them. Which begs the question: who - or what - is that system meant to protect? From Wondery, the network behind the hit podcast Dirty John, DR. DEATH is a story about a charming surgeon, 33 patients and a spineless system. Reported and hosted by Laura Beil.
This is what the news should sound like. The biggest stories of our time, told by the best journalists in the world. Hosted by Michael Barbaro. Twenty minutes a day, five days a week, ready by 6 a.m.
Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations.
If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks then look no further. Josh and Chuck have you covered.